Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Del Paggio

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Toxicity adjustment in the ESMO-MCBS: a gestalt approach?J C Del Paggio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Addressing the quality of the ESMO-MCBSJ C Del Paggio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2020
Cautionary tailsJ C Del Paggio, I F Tannock
Current Oncology (Toronto, Ont.)|January 5, 2017
Cancer care in South India: perspectives from visiting Canadian oncologistsS Karim, J C Del Paggio, S R Berry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapiesJ C Del Paggio, R Sullivan, W M Hopman, et al.
Current Oncology (Toronto, Ont.)|March 9, 2017
Lymph node evaluation for colon cancer in routine clinical practice: a population-based studyJ C Del Paggio, S Nanji, X Wei, et al.
The British Journal of Surgery|May 26, 2017
Population-based study to re-evaluate optimal lymph node yield in colonic cancerJ C Del Paggio, Y Peng, X Wei, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefitN Grössmann, J C Del Paggio, S Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?J C Del Paggio, B Azariah, R Sullivan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 4, 2021
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and InterpretationA Fundytus, J C Wells, S Sharma, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Toxicity adjustment in the ESMO-MCBS: a gestalt approach?J C Del Paggio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Addressing the quality of the ESMO-MCBSJ C Del Paggio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2020
Cautionary tailsJ C Del Paggio, I F Tannock
Current Oncology (Toronto, Ont.)|January 5, 2017
Cancer care in South India: perspectives from visiting Canadian oncologistsS Karim, J C Del Paggio, S R Berry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapiesJ C Del Paggio, R Sullivan, W M Hopman, et al.
Current Oncology (Toronto, Ont.)|March 9, 2017
Lymph node evaluation for colon cancer in routine clinical practice: a population-based studyJ C Del Paggio, S Nanji, X Wei, et al.
The British Journal of Surgery|May 26, 2017
Population-based study to re-evaluate optimal lymph node yield in colonic cancerJ C Del Paggio, Y Peng, X Wei, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefitN Grössmann, J C Del Paggio, S Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?J C Del Paggio, B Azariah, R Sullivan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 4, 2021
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and InterpretationA Fundytus, J C Wells, S Sharma, et al.
Pageof 1